Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Spinal Cord Injury

Li X., Wang C., Du K., Wang J., Lin J., Yang C.

Narrative Review on Spinal Cord Injury, Neuroinflammation, Scar, Chronic Inflammation, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41488862
PMCID
PMC12756966
DOI
10.2147/ijn.s573168
Citations
2

Abstract (original English)

Spinal cord injury (SCI) is a central nervous system injury caused by external forces or pathological factors, and traumatic SCI is the most common. If not treated promptly, traumatic SCI can cause secondary injury and neuroinflammation, leading to the proliferation of glial cells and formation of glial scars. Clinically, SCI is usually treated with surgical intervention, pharmacological therapy, or rehabilitation. However, good outcomes cannot be guaranteed. Therefore, SCI repair remains a central focus in neurotraumatic injury research. With an in-depth study of stem cells in nerve injury repair, stem cells and exosomes secreted by them have brought new hope for SCI treatment. Exosomes secreted by stem cells are small nano-sized vesicles, approximately 30-150 nm in diameter, that contain lipids, proteins, and nucleic acids. They can cross the blood-brain barrier (BBB) or blood-spinal cord barrier (BSCB) through the blood system, and the proteins or nucleic acid molecules they carry promote nerve repair. Existing studies have demonstrated that exosomes exert therapeutic effects on SCI through multiple mechanisms: miRNA-mediated modulation of inflammatory responses, promotion of axonal regeneration and angiogenesis, inhibition of glial scar formation and apoptosis, as well as regulation of target cell gene expression via signal transduction pathways mediated by their carried si

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Blood-Brain BarrierMesenchymal Stem CellsAnimalsHumansSpinal Cord InjuriesMicroRNAsNerve RegenerationExosomes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research